Testing Still Needed After HCV Clears in HIV-Positive MSM
A retrospective study found hepatitis C reinfection rates high are in HIV-positive men who have sex with men from four western European countries.
FDA Warns of Serious Slowing of Heart Rate with Hepatitis C Drugs and Amiodarone
The FDA approved label warning changes for two Gilead Sciences hepatitis C drugs after one person died and nine others had serious reactions when the drugs were coadministered with amiodarone, a drug used to treat irregular heartbeat.
Study Looks at Philadelphia Community-Based Hepatitis C Screening Program
A Philadelphia program operating in underserved neighborhoods found that residents chronically infected with the hepatitis C virus often lacked access to screening as well as treatment for the disease.
Study Shows Opioid Agonist Therapy May Prevent Spread of Hepatitis C Among Young Injection Drug Users
Researchers have found that maintenance treatment with methadone or buprenorphine may help prevent hepatitis C infection among injection drug users, a population with the highest risk of infection of the virus.
Federal Lawmakers Ask Gilead to Explain High Cost of Hepatitis C Drug
The US Senate Finance Committee recently requested detailed pricing information on Sovaldi (sofosbuvir), its breakthrough oral treatment for hepatitis C.
New Details about Hepatitis C Protein May Aid Development of Vaccine
Scientists have mapped the structure of a hepatitis C virus surface protein that is responsible for binding to host liver cells, leading to virus entry.
Serious Liver Disease Rates Higher Among Coinfected Patients
Study results show hepatic decompensation is more common in people who have both HIV and hepatitis C virus (HCV) compared to those infected only with HCV, an indication that early HCV treatment among coinfected patients is needed.
2 Clarke Drive Cranbury, NJ 08512